Table 5.
Comparison of standardized mortality ratios with other studies
| Author | Country | All cause SMR (95% CI) | Liver related SMR (95% CI) | Drug related SMR (95% CI) | |
|---|---|---|---|---|---|
| Amin [12] (2006) |
Australia |
HCV mono-infected |
3.1 (3.0-3.2) |
16.8 (15.4-18.3) |
19.3 (18.1-20.5) |
| HCV/HBV co-infected |
5.6 (4.8-6.6) |
32.9 (23.1-46.7) |
24.7 (18.2-33.5) |
||
| Duberg [13] (2008) |
Sweden |
HCV mono-infected |
5.8 (5.6-6.0) |
35.5 (32.9-38.3) |
20.7 (18.9-22.7) |
| HCV/HBV co-infected |
8.5 (7.3-9.8) |
46.2 (31.5-62.3) |
27.6 (19.6-39.6) |
||
| McDonald [15] (2008) |
Scotland |
HCV mono-infected |
4.9 (4.6-5.1) |
20.0 (17.9-22.2) |
23.5 (21.3-25.7) |
| HCV/HIV co-infected |
32.9 (29.2-37.0) |
34.8 (23.3-50.0) |
36.6 (25.2-51.4) |
||
| Yu (2012) | Canada | All HCV-infected |
4.8 (4.6-5.0) |
23.7 (21.9-25.7) |
20.7 (19.1-22.5) |
| REAC |
4.7 (4.5-4.9) |
23.9 (22.0-26.0) |
19.9 (18.3-21.7) |
||
| SERO | 10.1 (8.4-12.1) | 14.8 (6.4-29.1) | 36.7 (27.1-48.5) |
SMR=standardized mortality ratio; HCV=hepatitis C virus; HBV=hepatitis B virus; HIV=human immunodeficiency virus; REAC=reactive at first test; SERO=seroconverter.